GLP-1 Receptor Agonists for Pharmacologically Induced Weight Gain
This Viewpoint discusses the use of glucagon-like peptide-1 (GLP-1) receptor agonists as a strategy to manage psychotropic-induced weight gain.
Authors
- Mark Weiser (ORCID: https://orcid.org/0000-0003-3638-0271)
- Sharmili Edwin Thanarajah (ORCID: https://orcid.org/0000-0003-3608-1474)
- Nils Opel (ORCID: https://orcid.org/0000-0003-4749-3298)
- Marco Zierhut (ORCID: https://orcid.org/0000-0003-3109-9050)
Institutions
- Goethe University Frankfurt (DE)
- Tel Aviv University (IL)
- Sheba Medical Center (IL)
- Max Planck Institute for Metabolism Research (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- JAMA Psychiatry
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1001/jamapsychiatry.2025.2536
- Citations
- 1
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.39